期刊文献+
共找到490篇文章
< 1 2 25 >
每页显示 20 50 100
Recurrent acute pancreatitis as an initial presentation of primary hyperparathyroidism:A case report
1
作者 Masood M Karim Hira Raza Om Parkash 《World Journal of Clinical Cases》 SCIE 2024年第29期6302-6306,共5页
BACKGROUND With 4.9 to 35 instances per 100000 cases,hyperparathyroidism is one of the rarest causes of acute pancreatitis.The major cause of primary hyperparathyroidism is a parathyroid adenoma,which can manifest cli... BACKGROUND With 4.9 to 35 instances per 100000 cases,hyperparathyroidism is one of the rarest causes of acute pancreatitis.The major cause of primary hyperparathyroidism is a parathyroid adenoma,which can manifest clinically in various ways.CASE SUMMARY We discuss the unusual case of a 13-year-old boy with recurrent pancreatitis as the initial presentation of primary hyperparathyroidism.The cause of his recurrent pancreatitis remained unknown,and the patient had multiple admissions with acute pancreatitis over 3 years.His diagnosis was delayed due to the initial normal levels of parathyroid hormone,which were later reported elevated in a subsequent episode where ultrasound neck and thyroid scintigraphy revealed a parathyroid adenoma as the underlying cause.After the diagnosis was made,he underwent surgical resection of the adenoma.CONCLUSION This case study stresses the importance of considering uncommon causes for recurrent pancreatitis. 展开更多
关键词 Recurrent pancreatitis Primary hyperparathyroidism Normal serum parathyroid hormone parathyroid adenoma Case report
下载PDF
Hyperparathyroidism presented as multiple pulmonary nodules in hemodialysis patient status post parathyroidectomy:A case report
2
作者 Ping-Han Chiang Kai-Hsiung Ko +2 位作者 Yi-Jen Peng Tsai-Wang Huang Shih-En Tang 《World Journal of Radiology》 2024年第9期466-472,共7页
BACKGROUND Primary hyperparathyroidism is typically caused by a single parathyroid adenoma.Ectopic parathyroid adenomas occur as well,with cases involving various sites,including the mediastinum,presenting in varying ... BACKGROUND Primary hyperparathyroidism is typically caused by a single parathyroid adenoma.Ectopic parathyroid adenomas occur as well,with cases involving various sites,including the mediastinum,presenting in varying frequencies.Secondary hyperparathyroidism develops in the context of chronic kidney disease,primarily due to vitamin D deficiency,hypocalcemia,and hyperphosphatemia.It is frequently diagnosed in patients undergoing dialysis.This article presents a rare case of hyperparathyroidism involving multiple hyperplastic parathyroid glands with pulmonary seeding in a 50-year-old female patient undergoing hemodialysis(HD).CASE SUMMARY The patient had a history of parathyroidectomy 10 years prior but developed recurrent hyperparathyroidism with symptoms of pruritus and cough with sputum during a period of routine dialysis.Radiographic imaging revealed multiple nodules in both lungs,with the largest measuring approximately 1.35 cm.Surgical histopathology confirmed the presence of hyperplastic parathyroid glands within the pulmonary tissue.After tumor resection surgery via videoassisted thoracic surgery with wedge resection,the patient was discharged in stable condition and in follow-up her symptoms showed improvement.CONCLUSION This article describes hyperparathyroidism presenting as pulmonary nodules in a patient undergoing postparathyroidectomy HD,highlighting diagnostic challenges and a positive outcome from tumor resection surgery. 展开更多
关键词 HYPERTENSION End-stage renal disease hyperparathyroidism Pulmonary nodules HEMODIALYSIS Video-assisted thoracic surgery Hyperplastic parathyroid glands Case report
下载PDF
Update on the current management of persistent and recurrent primary hyperparathyroidism after parathyroidectomy
3
作者 Efstathios T Pavlidis Theodoros E Pavlidis 《World Journal of Clinical Cases》 SCIE 2023年第10期2213-2225,共13页
Primary hyperparathyroidism(pHPT)is the third most common endocrine disease.The surgical procedure aims for permanent cure,but recurrence has been reported in 4%-10%of pHPT patients.Preoperative localization imaging i... Primary hyperparathyroidism(pHPT)is the third most common endocrine disease.The surgical procedure aims for permanent cure,but recurrence has been reported in 4%-10%of pHPT patients.Preoperative localization imaging is highly valuable.It includes ultrasound,computed tomography(CT),single-photonemission CT,sestamibi scintigraphy and magnetic resonance imaging.The operation has been defined as successful when postoperative continuous eucalcemia exists for more than the first six months.Ongoing hypercalcemia during this period is defined as persistence,and recurrence is defined as hypercalcemia after six months of normocalcemia.Vitamin D is a crucial factor for a good outcome.Intraoperative parathyroid hormone(PTH)monitoring can safely predict the outcomes and should be suggested.PTH≤40 pg/mL or the traditional decrease≥50%from baseline minimizes the likelihood of persistence.Risk factors for persistence are hyperplasia and normal parathyroid tissue on histopathology.Risk factors for recurrence are cardiac history,obesity,endoscopic approach and low-volume center(at least 31 cases/year).Cases with double adenomas or four-gland hyperplasia have a greater likelihood of persistence/recurrence.A 6-mo calcium>9.7 mg/dL and eucalcemic parathyroid hormone elevation at 6 mo may be associated with recurrence necessitating long-term follow-up.18F-fluorocholine positron emission tomography and 4-dimensional CT in persistent and recurrent cases can be valuable before reoperation.With these novel advances in preoperative imaging and localization as well as intraoperative PTH measurement,the recurrence rate has dropped to 2.5%-5%.Sixmonth serum calcium≥9.8 mg/dL and parathyroid hormone≥80 pg/mL indicate a risk of recurrence.Negative sestamibi scintigraphy,diabetes and elevated osteocalcin levels are predictors of multiglandular disease,which brings an increased risk of persistence and recurrence.Bilateral neck exploration was considered the gold-standard diagnostic method.Minimally invasive parathyroidectomy and neck exploration are both effective surgical techniques.Multidisciplinary diagnostic and surgical management is required to prevent persistence and recurrence.Long-term follow-up,even up to 10 years,is necessary. 展开更多
关键词 parathyroid hormone Minimally invasive parathyreoidectomy hyperparathyroidism Primary REOPERATION PERSISTENT Recurrent hypercalcemia
下载PDF
术中及围手术期血清iPTH监测对501例继发性甲状旁腺功能亢进患者手术效果的精准诊断研究——“Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients”的二 被引量:5
4
作者 张丽娜 邢昌赢 +12 位作者 沈冲 曾鸣 杨光 毛慧娟 张波 俞香宝 孙彬 欧阳春 葛益飞 江瑶 尹彩霞 查小明 王宁宁 《中国血液净化》 2017年第4期227-233,共7页
目的甲状旁腺切除术(parathyroidectomy,PTX)是继发性甲状旁腺功能亢进患者(secondary hyperparathyroidism,SHPT)的有效治疗方式,然而由于甲状旁腺位置和数目异常的存在,部分患者术后SHPT仍持续存在。本研究探讨PTX患者术中及围手术期... 目的甲状旁腺切除术(parathyroidectomy,PTX)是继发性甲状旁腺功能亢进患者(secondary hyperparathyroidism,SHPT)的有效治疗方式,然而由于甲状旁腺位置和数目异常的存在,部分患者术后SHPT仍持续存在。本研究探讨PTX患者术中及围手术期血清全段甲状旁腺激素(intact parathyroid hormone,iPTH)监测对手术效果精准诊断的意义。方法记录501例行甲状旁腺全切+自体前臂移植术(不伴胸腺切除)的慢性肾脏病患者的术中及围手术期血清iPTH值。术后一周内患者血清iPTH≤50 pg/ml为手术成功;若>50 pg/ml则在6月内进行随访,随访血清iPTH<300 pg/mL即为手术成功,否则为SHPT持续存在。结果 433例(86.4%)患者手术成功,49例(9.8%)患者SHPT持续存在,19例(3.8%)患者缺乏有效随访归为手术效果未知组。肝炎(n=204)与非肝炎(n=297)患者比较,基线血清iPTH水平及术中血清iPTH下降百分比无显著统计学差异(P>0.05)。受试者工作特征(receiver operating characteristic,ROC)曲线结果表明术后20分钟血清iPTH下降≥88.9%提示手术成功(曲线下面积0.909,敏感度78.6%,特异度88.5%)。术后4天血清iPTH≥147.4 pg/ml提示SHPT持续存在(曲线下面积0.998,敏感度100%,特异度99.5%)。结论甲状旁腺切除术中血清iPTH监测能提示甲状旁腺切除是否彻底,避免对患者不必要的探查,降低手术并发症的发生率。围手术期血清iPTH监测提示SHPT是否持续存在,对此类患者需密切随访、及时开始药物治疗或必要时再次手术。 展开更多
关键词 术中 围手术期 甲状旁腺激素 甲状旁腺切除术 继发性甲状旁腺功能亢进
下载PDF
Acute necrotizing pancreatitis as fi rst manifestation of primary hyperparathyroidism 被引量:10
5
作者 Jeroen I Lenz Jimmy M Jacobs +3 位作者 Bart Op de Beeck Ivan A Huyghe Paul A Pelckmans Tom G Moreels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第23期2959-2962,共4页
We report the case of a female patient with severe acute necrotizing pancreatitis associated with hypercalcemia as first manifestation of primary hyperparathyroidism caused by a benign parathyroid adenoma.Initially th... We report the case of a female patient with severe acute necrotizing pancreatitis associated with hypercalcemia as first manifestation of primary hyperparathyroidism caused by a benign parathyroid adenoma.Initially the acute pancreatitis was treated conservatively.The patient subsequently underwent surgical resection of the parathyroid adenoma and surgical clearance of a large infected pancreatic pseudocyst.Although the association of parathyroid adenoma-induced hypercalcemia and acute pancreatitis is a known medical entity,it is very uncommon.The pathophysiology of hypercalcemia-induced acute pancreatitis is therefore not well known,although some mechanisms have been proposed.It is important to treat the provoking factor.Therefore,the cause of hypercalcemia should be identif ied early.Surgical resection of the parathyroid adenoma is the ultimate therapy. 展开更多
关键词 Acute necrotizing pancreatitis HYPERCALCEMIA Primary hyperparathyroidism parathyroid adenoma
下载PDF
Parathyroid and bone imaging in primary hyperparathyroidism 被引量:3
6
作者 ZHURui-Sen LUHan-Kui +2 位作者 LUOQuan-Yong CHENLi-Bo MAJi-Xiao 《Nuclear Science and Techniques》 SCIE CAS CSCD 2004年第5期272-276,共5页
Skeletal derangements occur quite often in patient with primary hyperparathyroidism (PHPT). We investigated parathyroid and bone imagings in 59 cases of pathologically proven PHPT. Forty-nine cases were pathologically... Skeletal derangements occur quite often in patient with primary hyperparathyroidism (PHPT). We investigated parathyroid and bone imagings in 59 cases of pathologically proven PHPT. Forty-nine cases were pathologically proven parathyroid adenomas; 8 presented hyperplasia and the other 2 were adenocarcinomas. Parathyroid imaging (early phase imaging, EPI) was conducted at 30 min after injecting 740~925MBq 99mTc-MIBI and 2~3h later (delayed phase imaging, DPI) separately. The following thyroid imagings were performed at the same posture 10 min after intravenous injection of 74~111MBq 99mTcO4-. The 99mTc- MIBI subtraction imaging data were obtained by subtracting thyroid imaging from that of DPI. Among 49 cases of proven hyperparathyroid adenoma 45 yielded positive imagings. Eight cases with hyperplasia gave negative results. The results were positive in 2 cases of parathyroid adenocarcinoma. Results of 99mTc-MDP/bone imaging: 35 cases of hyperparathyroid adenocarcinoma (disease duration 1-6 months) showed normal bone images, while 14 cases showed superscan images, course being 4-12 months. Bone imaging for 2 cases of adenocarcinoma showed multiple, radioactive aggregated foci (brown tumor imaging); course lasting 10-24 months. The results of bone imaging in 8 cases of hyperplasia/ hyperparathyroidism were normal. It was concluded that diagnostic accuracy for parathyroid was 79.6% and for parathyroid adenoma was 91.8%, and the technique has no diagnostic value for hyperplasia. The 99mTc-MDP / bone imaging results for PHPT can be classified into three categories, i.e. normal, superscan and brown tumor. The imaging results correlated well with the different categories and degrees of bone damage, the duration of clinical course and the pathological types. Therefore, it's important to use bone imaging data in association with therapy to reflect the stage and progress of PHPT. 展开更多
关键词 PHPT ^99MTC-MDP MB ^99mTcO4^- MIB DPI
下载PDF
Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism 被引量:2
7
作者 Cláudia Ribeiro Maria Goretti Moreira Guimaraes Penido +5 位作者 Milena Maria Moreira Guimaraes Marcelo de Sousa Tavares Bruno das Neves Souza Anderson Ferreira Leite Leonardo Martins Caldeira de Deus Lucas Joséde Campos Machado 《World Journal of Nephrology》 2016年第5期437-447,共11页
AIM To evaluate the parathyroid ultrasonography and define parameters that can predict poor response to treatment in patients with secondary hyperparathyroidism due to renal failure.METHODS This cohort study evaluated... AIM To evaluate the parathyroid ultrasonography and define parameters that can predict poor response to treatment in patients with secondary hyperparathyroidism due to renal failure.METHODS This cohort study evaluated 85 patients with chronic kidney disease stage V with parathyroid hormone levels above 800 pg/mL. All patients underwent ultrasonography of the parathyroids and the following parameters were analyzed: Demographic characteristics(etiology of chronic kidney disease, gender, age, dialysis vintage, vascular access, use of vitamin D), laboratory(calcium, phosphorus, parathyroid hormone, alkaline phosphatase, bone alkaline phosphatase), and the occurrence of bone changes, cardiovascular events and death. The χ~2 test were used to compare proportions or the Fisher exact test for small sample frequencies. Student t-test was used to detect differences between the two groups regarding continuous variables.RESULTS Fifty-three patients(66.4%) had parathyroid nodules with higher levels of parathyroid hormone, calcium and phosphorus. Sixteen patients underwent parathyroidectomy and had higher levels of phosphorus and calcium × phosphorus product(P = 0.03 and P = 0.006, respectively). They also had lower mortality(32% vs 68%, P = 0.01) and lower incidence of cardiovascular or cerebrovascular events(27% vs 73%, P = 0.02). Calcium × phosphorus product above 55 mg^2/dL^2 [RR 1.48(1.06, 2.08), P = 0.03], presence of vascular calcification [1.33(1.01, 1.76), P = 0.015] and previous occurrence of vascular events [RR 2.25(1.27, 3.98), P < 0.001] were risk factors for mortality in this population. There was no association between the occurrence of nodules and mortality.CONCLUSION The identification of nodules at ultrasonography strengthens the indication for parathyroidectomy in patients with secondary hyperparathyroidism due to renal failure. 展开更多
关键词 Secondary hyperparathyroidism parathyroid ultrasonography CALCIUM PHOSPHORUS parathyroid hormone Alkaline phosphatase Chronic kidney disease Bone alkaline phosphatase
下载PDF
Primary hyperparathyroidism presenting as acute pancreatitis: An institutional experience with review of the literature 被引量:1
8
作者 K G Rashmi Sadishkumar Kamalanathan +6 位作者 Jayaprakash Sahoo Dukhabandhu Naik Pazhanivel Mohan Biju Pottakkat Sitanshu Sekhar Kar Rajan Palui Ayan Roy 《World Journal of Gastrointestinal Pharmacology and Therapeutics》 2022年第4期47-56,共10页
BACKGROUND Acute pancreatitis(AP)presenting as an initial manifestation of primary hyperparathyroidism(PHPT)is uncommon,and its timely diagnosis is crucial in preventing recurrent attacks of pancreatitis.AIM To determ... BACKGROUND Acute pancreatitis(AP)presenting as an initial manifestation of primary hyperparathyroidism(PHPT)is uncommon,and its timely diagnosis is crucial in preventing recurrent attacks of pancreatitis.AIM To determine the clinical,biochemical,and radiological profile of PHPT patients presenting as AP.METHODS This is a retrospective observational study,51 consecutive patients admitted with the diagnosis of PHPT during January 2010 and October 2021 at a tertiary care hospital in Puducherry,India was included.The diagnosis of AP was established in the presence of at least two of the three following features:abdominal pain,levels of serum amylase or lipase greater than three times the normal,and characteristic features at abdominal imaging.RESULTS Out of the 51 consecutive patients with PHPT,twelve(23.52%)had pancreatitis[5(9.80%)AP,seven(13.72%)chronic pancreatitis(CP)].PHPT with AP(PHPT-AP)was more common among males with the presentation at a younger age(35.20±16.11 vs 49.23±14.80 years,P=0.05)and lower plasma intact parathyroid hormone(iPTH)levels[125(80.55-178.65)vs 519.80(149-1649.55,P=0.01)]compared to PHPT without pancreatitis(PHPT-NP).The mean serum calcium levels were similar in both PHPT-AP and PHPT-NP groups[(11.66±1.15 mg/dL)vs(12.46±1.71 mg/dL),P=0.32].PHPT-AP also presented with more gastrointestinal symptoms like abdominal pain,nausea,and vomiting with lesser skeletal and renal manifestations as compared to patients with PHPT-NP.CONCLUSION AP can be the only presenting feature of PHPT.Normal or higher serum calcium levels during AP should always draw attention towards endocrine causes like PHPT. 展开更多
关键词 Acute pancreatitis Chronic pancreatitis parathyroid hormone Primary hyperparathyroidism Skeletal manifestations
下载PDF
Primary hyperparathyroidism in a woman with multiple tumors: A case report
9
作者 Can-Can Hui Xue Zhang +1 位作者 Jian-Ran Sun Da-Tong Deng 《World Journal of Clinical Cases》 SCIE 2019年第19期3132-3137,共6页
BACKGROUND Parathyroid adenoma(PTA)is known as an adenomatous hyperparathyroidism syndrome.At earlier times,the major symptoms of this disease included high blood calcium and low phosphorus.PTA is a benign neuroendocr... BACKGROUND Parathyroid adenoma(PTA)is known as an adenomatous hyperparathyroidism syndrome.At earlier times,the major symptoms of this disease included high blood calcium and low phosphorus.PTA is a benign neuroendocrine neoplasm.We have reviewed the literature and found that it is rare for patients with hyperparathyroidism to have benign tumors with multiple organs at the same time.This report describes a patient with a PTA and four nonfunctional adenomas.CASE SUMMARY We report a case of primary hyperparathyroidism in a 39-year-old woman with multiple organ tumors.The patient was admitted to hospital because of hypercalcemia.Laboratory,imaging,and histological examinations confirmed a left parathyroid neoplasm.Right thyroid adenoma was discovered during hospitalization.She had a medical history of uterine fibroids,right benign mammary gland tumor,and meningioma.The patient recovered after surgical and conservative treatments.CONCLUSION Primary hyperparathyroidism with multiple organ tumors is uncommon,and further studies should be conducted to determine if there is genetic heterogeneity. 展开更多
关键词 Primary hyperparathyroidism parathyroid NEOPLASM THYROID ADENOMA MENINGIOMA Breast NEOPLASM Case report
下载PDF
Diagnostic Performance and Inter-Observer Agreement of 4-Dimensional Computed Tomography Parathyroid Scans in Patients with Primary and Secondary Hyperparathyroidism
10
作者 Bundhit Tantiwongkosi Frank R. Miller +6 位作者 Viet D. Nguyen Kathleen E. Hands Boyce B. Oliver Alfredo A. Santillan Wilson B. Altmeyer Achint K. Singh Fang Yu 《Open Journal of Radiology》 2019年第1期82-91,共10页
Background: 4D-CT has been used to localize the parathyroid adenomas and hyperplasia since 2006 as a second line study after TC-99 m MIBI and ultrasonography. However, multiple studies have shown that 4D-CT is a robus... Background: 4D-CT has been used to localize the parathyroid adenomas and hyperplasia since 2006 as a second line study after TC-99 m MIBI and ultrasonography. However, multiple studies have shown that 4D-CT is a robust imaging method with high diagnostic accuracy, becoming increasingly popular among surgeons and radiologists. Purpose: To assess the diagnostic performance of 4D-CT scans to identify the pathologic gland(s), using pathology and intraoperative findings as gold standards. Methods: We analyzed patients with primary and secondary hyperparathyroidism who had intraoperative reports, pathology, parathyroid hormone levels, and preoperative 4D-CT. Histology, surgical findings, and decreased parathyroid hormone levels were used as gold standards. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy and 95% confidence interval were calculated. Fleiss’ kappa was used to assess the inter-observer agreement. Results: Sixty-seven patients were included. Sixty-two patients had a single adenoma, and five patients had a multiple gland disease (adenomas or hyperplasia). A total of 72 glands were proven to have parathyroid adenomas or hyperplasia. The sensitivity, specificity, PPV, NPV and accuracy are 85%, 97%, 96%, 87% and 91% for lateralization and 76%, 96%, 85%, 92% and 90% for quadrant localization, respectively in single-gland disease. The sensitivity, specificity, PPV, NPV and accuracy are 88%, 100%, 100%, 50% and 90% for lateralization and 71%, 100%, 100%, 60% and 80% for quadrant localization respectively in multiple-gland disease. Fleiss’ kappa value is 5.6 (moderate inter-observer agreement). Conclusion: 4D-CT is a robust method in the localization of hyperfunctioning parathyroid glands with high accuracy and at least moderate inter-observer agreement. 展开更多
关键词 COMPUTED TOMOGRAPHY parathyroid 4-Dimensional hyperparathyroidism
下载PDF
Lithium Associated Hyperparathyroidism: An Evidence Based Surgical Approach
11
作者 Umashankar K Ballehaninna Steven M. Nguyen Ronald S. Chamberlain 《Surgical Science》 2011年第10期468-475,共8页
Background: Long-term lithium use in psychiatric patients may lead to lithium associated hyperparathyroidism (LAH). Although anecdotal case reports have appeared, an evidence based algorithm for management of LAH is l... Background: Long-term lithium use in psychiatric patients may lead to lithium associated hyperparathyroidism (LAH). Although anecdotal case reports have appeared, an evidence based algorithm for management of LAH is lacking. Methods: A comprehensive literature search was performed (1973-2010) using PubMed with keywords;“lithium” “hypercalcemia” “hyperparathyroidism” “sestamibi” “intra-operative parathyroid hormone (IOPTH) monitoring” “parathyroidectomy” and “medical management”. All English language publications addressing etiology and clinical management issues concerning LAH were critically analyzed. Results: Lithium associated hyperparathyroidism occurs in 4.3% - 6.3% of chronic lithium users compared to the general population which has an incidence of 0.5% - 1%. 194 cases of LAH have been reported which includes 10 patients (5%) treated medically and 170 patients (88%) who underwent parathyroidectomy. No details were available for 14 patients (7%). Among parathyroidectomy patients, 104 (59%) had adenomatous disease and 66 (39%) had multiglandular hyperplasia. Preoperative localization studies were utilized in only 22 patients (13%) and IOPTH monitoring was reported in only 3 studies (32 patients, 19%). Among surgical patients, bilateral neck exploration (BNE) was the most common approach performed in 162 patients (95%);focused neck exploration was utilized in only 8 patients (5%). Parathyroidectomy normalized LAH biochemical changes in nearly all patients (90% - 97%) in the early post-operative period, but recurrent hyperparathyroidism occurred in 8% - 42% of patients. Conclusion: LAH is an under appreciated and poorly understood endocrine disorder. LAH has a higher incidence of multiglandular disease and bilateral neck exploration is mandatory in majority for disease control. Nonsurgical approaches may be useful in select patients on short-term lithium therapy. 展开更多
关键词 LITHIUM HYPERCALCEMIA hyperparathyroidism SESTAMIBI Intra-Operative parathyroid Hormone (IOPTH) Monitoring parathyroidECTOMY Medical Management
下载PDF
Minimally Invasive Mediastinal Parathyroidectomy: An Effective and Safe Technique in Patients with Ectopic Primary Hyperparathyroidism
12
作者 Iskander Al-Githmi 《Open Journal of Thoracic Surgery》 2017年第4期70-76,共7页
Introduction: Primary hyperparathyroidism is a disease commonly caused by a single parathyroid adenoma in 80% - 85% of cases, and is less frequently caused by parathyroid hyperplasia. In approximately 2% of cases, the... Introduction: Primary hyperparathyroidism is a disease commonly caused by a single parathyroid adenoma in 80% - 85% of cases, and is less frequently caused by parathyroid hyperplasia. In approximately 2% of cases, the ectopic parathyroid adenoma is located within the mediastinum. Safely targeted parathyroidectomy is the gold standard procedure for surgical management of primary hyperparathyroidism. We reviewed our surgical experience using video-assisted thoracic surgery and a robotic technique for surgical resection of mediastinal parathyroid adenoma, caused by primary hyperparathyroidism. Materials and Methods: From July 2010 to September 2016, six consecutive patients with symptomatic primary hyperparathyroidism were evaluated with neck ultrasound computed tomography (CT), technetium-99 sestamibi scintigraphy, and selective venous sampling with a measurement of parathyroid hormone levels. Four patients underwent video-assisted thoracic parathyroidectomy and two patients had robotic-assisted parathyroidectomy. Results:? In six patients, there were four women and two men with a mean age of 47.5 years (ranging from 31 - 60 years). The mediastinal parathyroid adenomas were successfully localized by preoperative imaging studies in five patients. Only in one patient, we were unable to localize the parathyroid adenoma. All parathyroid adenomas were successfully resected without any complications. Conclusions: We found that minimally invasive mediastinal parathyroidectomy is promising, safe, and effective in a selected group of patients, as well as providing superior cosmetic results and a short hospital stay. 展开更多
关键词 Primary hyperparathyroidism parathyroid Adenoma Minimally Invasive parathyroidECTOMY MEDIASTINUM
下载PDF
The Role of Preoperative Ultrasound and Sestamibi Scintigraphy in the Surgical Management of Primary Hyperparathyroidism: A Review of Literature
13
作者 Daniel Margain Rodrigo Arrangoiz +10 位作者 Adrian Legaspi Vanitha Vasudevan Amit Sastry Frank De La Cruz Jeronimo Garcialopez De Llano Jennifer Fernandez Loisani Galindo Noah Llaneras Matthew Farrell Gonzalo Fernandez-Christlieb Fernando Cordera 《International Journal of Otolaryngology and Head & Neck Surgery》 2022年第2期91-105,共15页
Background: Primary hyperparathyroidism (pHPT) is one of the most common endocrine diseases and the most common cause of hypercalcemia. Since routine laboratory testing, the prevalence of the disease has increased fro... Background: Primary hyperparathyroidism (pHPT) is one of the most common endocrine diseases and the most common cause of hypercalcemia. Since routine laboratory testing, the prevalence of the disease has increased from 0.1% to 0.4% worldwide. The only curative treatment is parathyroidectomy. Nowadays, preoperative localization studies have become standard before surgical treatment, and the first stage imaging methods are cervical ultrasonography (US) and/or Sestamibi scintigraphy. Objectives: To describe the accuracy of US and Sestamibi for detection of hyperfunctioning parathyroid adenomas preoperatively in patients with confirmed pHPT from our medical institution. Results: This is a retrospective study from a prospectively kept database that included thirty-one patients with the confirmed diagnosis of pHPT clinically and biochemically. The average age was 57.8 years old. Preoperative US and surgery findings were compared with a sensitivity of 51%. Preoperative Sestamibi and surgery findings were compared resulting in a sensitivity of 71%. Both imaging methods combined, resulted in a sensitivity of 80%. Conclusion: In patients with pHPT, Sestamibi is an effective method for localizing parathyroid pathology preoperatively, but the false negative rate can be high. US tends to have a wider range explained by the operator-dependent factor. The combination of US and Sestamibi reduces the rate of false negatives, as reported in international literature. It is important to mention that these studies cannot be used as a confirmatory test for this disease. It should only be used as an adjunct to help plan the operation. 展开更多
关键词 parathyroid Glands Primary hyperparathyroidism parathyroid Adenoma parathyroid Hyperplasia parathyroidECTOMY Cervical Ultrasound Sestamibi Scintigraphy Limited Neck Exploration
下载PDF
依特卡肽治疗糖尿病肾病维持性血液透析继发甲状旁腺功能亢进的疗效观察 被引量:1
14
作者 马世兴 仇琳 王勤超 《川北医学院学报》 CAS 2024年第8期1049-1051,1055,共4页
目的:探究依特卡肽治疗糖尿病肾病维持性血液透析(MHD)继发性甲状旁腺功能亢进(SHPT)的疗效。方法:根据治疗药物不同将92例糖尿病肾病MHD引起的SHPT患者分为研究组和对照组,每组各46例。研究组给予依特卡肽治疗;对照组给予西那卡塞治疗... 目的:探究依特卡肽治疗糖尿病肾病维持性血液透析(MHD)继发性甲状旁腺功能亢进(SHPT)的疗效。方法:根据治疗药物不同将92例糖尿病肾病MHD引起的SHPT患者分为研究组和对照组,每组各46例。研究组给予依特卡肽治疗;对照组给予西那卡塞治疗,两组均持续治疗3个月。比较治疗前后的两组患者的甲状旁腺指标、生化指标、成纤维细胞生长因子23(FGF23)水平、骨代谢指标差异;记录并比较两组患者不良反应发生情况。结果:治疗后,两组患者甲状旁腺指标、生化指标、FGF23水平、骨代谢指标均降低(P<0.05),且研究组低于对照组(P<0.05);研究组患者不良反应发生率低于对照组(P<0.05)。结论:依特卡肽治疗糖尿病肾病MHD继发SHPT患者可有效改善患者甲状旁腺功能。 展开更多
关键词 糖尿病肾病 维持性血液透析 继发性甲状旁腺功能亢进 甲状腺指标
下载PDF
帕立骨化醇联合西那卡塞治疗甲状旁腺功能亢进临床观察
15
作者 王莉 王荣忠 余少斌 《中国药业》 2024年第3期109-111,共3页
目的探讨帕立骨化醇联合西那卡塞治疗甲状旁腺功能亢进(简称甲旁亢)的临床疗效。方法选取医院2021年1月至2022年8月收治的甲旁亢患者70例,按随机信封法分为对照组和观察组,各35例。两组患者均予西那卡塞治疗,观察组加用帕立骨化醇,均连... 目的探讨帕立骨化醇联合西那卡塞治疗甲状旁腺功能亢进(简称甲旁亢)的临床疗效。方法选取医院2021年1月至2022年8月收治的甲旁亢患者70例,按随机信封法分为对照组和观察组,各35例。两组患者均予西那卡塞治疗,观察组加用帕立骨化醇,均连续治疗6个月。结果观察组总有效率为97.14%,显著高于对照组的74.29%(P<0.05);两组患者治疗后的疼痛程度评分、甲状旁腺体积、甲状旁腺激素水平均显著降低(P<0.05),且观察组均显著低于对照组(P<0.05);观察组与对照组治疗期间不良反应发生率相当(14.29%比2.86%,P>0.05)。结论帕立骨化醇联合西那卡塞治疗甲旁亢的临床疗效良好,能缓解患者的疼痛程度,缩小甲状旁腺体积,降低甲状旁腺激素水平,且安全性良好。 展开更多
关键词 帕立骨化醇 西那卡塞 甲状旁腺功能亢进 疼痛程度 甲状旁腺体积 临床疗效
下载PDF
维持性血液透析继发性甲状旁腺功能亢进患者甲状旁腺增生超声临床特点及误诊原因分析
16
作者 徐蓉 田慧 +1 位作者 吴迎春 吕康泰 《临床误诊误治》 CAS 2024年第10期16-22,共7页
目的探讨维持性血液透析继发性甲状旁腺功能亢进(SHPT)患者甲状旁腺增生超声临床特点及误诊原因。方法选择2021年4月至2023年2月维持性血液透析SHPT 190例为研究对象,比较不同程度SHPT患者超声特征,分析超声对SHPT患者甲状旁腺增生的诊... 目的探讨维持性血液透析继发性甲状旁腺功能亢进(SHPT)患者甲状旁腺增生超声临床特点及误诊原因。方法选择2021年4月至2023年2月维持性血液透析SHPT 190例为研究对象,比较不同程度SHPT患者超声特征,分析超声对SHPT患者甲状旁腺增生的诊断效能,多因素Logistic回归分析超声误诊的相关影响因素。再根据甲状旁腺是否增生分为增生组(n=127)和对照组(n=63),建立多因素Logistic回归模型分析SHPT患者甲状旁腺增生的独立危险因素,并分析不同方法对甲状旁腺增生的诊断效能。结果随SHPT严重程度的加重,多枚增生、低回声、结节形态不规则、结节血供丰富、内部回声不均匀、出现钙化的比例也随之升高。超声检查甲状旁腺增生的敏感度为0.881,特异度为0.657,误诊率为34.29%,漏诊率为11.86%。结节最大径、结节形态及结节血供均为超声误诊SHPT患者甲状旁腺增生的影响因素(P<0.05)。透析时间、碱性磷酸酶、血磷及甲状旁腺素水平是影响SHPT患者甲状旁腺增生的独立危险因素(P<0.01)。超声检查、Logistic回归模型及联合诊断甲状旁腺增生的受试者工作特征曲线下面积分别为0.773、0.754、0.889,其中联合诊断最高,并且准确性(0.840)和约登指数(0.679)均高于其他方法。结论随着维持性血液透析患者SHPT严重程度的加重,甲状旁腺形态结构改变越发显著,超声检查甲状旁腺增生误诊率较高,结节形态、结节最大径及结节血供对超声检查诊断结果具有显著影响。超声联合Logistic回归模型诊断SHPT患者甲状旁腺增生,具有较高价值。 展开更多
关键词 维持性血液透析 甲状旁腺功能亢进 继发性 甲状旁腺素 超声检查 误诊 增生 危险因素 诊断
下载PDF
西那卡塞联合碳酸司维拉姆治疗血液透析并发SHPT患者的临床效果
17
作者 邓莹 郭晓超 《临床医学研究与实践》 2024年第32期47-50,共4页
目的探讨西那卡塞联合碳酸司维拉姆治疗血液透析并发继发性甲状旁腺功能亢进症(SHPT)患者的临床效果。方法选取2019年12月至2022年12月汉中市中心医院肾内科收治的100例血液透析并发SHPT患者为研究对象,采用随机数字表法将其分为对照组... 目的探讨西那卡塞联合碳酸司维拉姆治疗血液透析并发继发性甲状旁腺功能亢进症(SHPT)患者的临床效果。方法选取2019年12月至2022年12月汉中市中心医院肾内科收治的100例血液透析并发SHPT患者为研究对象,采用随机数字表法将其分为对照组与联用组,各50例。对照组使用碳酸司维拉姆治疗,联用组使用西那卡塞联合碳酸司维拉姆治疗。比较两组的治疗效果。结果治疗后,联用组的血钙、血磷及全段甲状旁腺激素(iPTH)达标率高于对照组(P<0.05)。治疗后,两组的碱性磷酸酶(AKP)水平、钙磷乘积均显著降低,且联用组低于对照组(P<0.05)。治疗后,两组的甲状旁腺长度、宽度、厚度及体积均显著减小,且联用组小于对照组(P<0.05)。联用组的治疗总有效率高于对照组(P<0.05)。药物治疗期间,联用组的非致死性心血管不良事件发生率低于对照组(P<0.05)。结论西那卡塞联合碳酸司维拉姆治疗血液透析并发SHPT患者的临床效果较好,可有效保持钙磷代谢平衡、改善iPTH水平、缩小甲状旁腺体积以及降低心血管不良事件发生率,有利于患者的长期生存。 展开更多
关键词 继发性甲状旁腺功能亢进症 血液透析 西那卡塞 碳酸司维拉姆 甲状旁腺体积
下载PDF
吲哚菁绿联合近红外自体荧光在甲状旁腺病变识别中的应用初探
18
作者 刘瑞鸣 李祖飞 +3 位作者 钟琦 张洋 黄志刚 黄俊伟 《中国耳鼻咽喉头颈外科》 CSCD 2024年第9期545-548,共4页
目的探索吲哚菁绿联合近红外自体荧光成像技术在原发性甲状旁腺功能亢进(primary hyperparathyroidism,PHPT)手术中识别病变甲状旁腺的应用价值。方法收集就诊于首都医科大学附属北京同仁医院的40例PHPT患者数据,所有患者均行手术治疗... 目的探索吲哚菁绿联合近红外自体荧光成像技术在原发性甲状旁腺功能亢进(primary hyperparathyroidism,PHPT)手术中识别病变甲状旁腺的应用价值。方法收集就诊于首都医科大学附属北京同仁医院的40例PHPT患者数据,所有患者均行手术治疗切除病变甲状旁腺。其中吲哚菁绿给药组10例,非给药组30例。采用近红外自体荧光成像仪进行图像采集,ImageJ软件进行荧光强度分析。结果吲哚菁绿给药组的病变甲状旁腺荧光强度显著高于非给药组(142.7±23.7 vs.94.5±31.4,t=-4.434,P=0.000);病变甲状旁腺/甲状腺荧光比值显著高于非给药组(1.6±0.3 vs.1.2±0.4,t=-3.162,P=0.004)。非给药组甲状旁腺荧光强度与术前血钙(r=0.029,P=0.088)及术前甲状旁腺激素(PTH)(r=-0.142,P=0.455)均无相关性,给药组甲状旁腺荧光强度与术前血钙(r=0.206,P=0.568)及术前PTH(r=0.160,P=0.658)均无相关性。非给药组近红外光检出率为53.3%(16/30),给药组近红外光检出率为100%(10/10)。非给药组的平均检出时间为(71.0±16.9)min,给药组的平均检出时间为(52.7±11.1)min,差异比较有统计学意义(t=3.187,P=0.003)。结论吲哚菁绿联合近红外自体荧光成像技术有助于在PHPT手术治疗中识别病变甲状旁腺。 展开更多
关键词 甲状旁腺功能亢进 原发性 甲状旁腺 近红外自体荧光 吲哚菁绿
下载PDF
骨化三醇联合西那卡塞对继发性甲状旁腺功能亢进的疗效及安全性分析 被引量:1
19
作者 陈翠玲 陈丽玲 +2 位作者 汪剑云 罗玉钊 张水燕 《中国医药科学》 2024年第4期79-83,共5页
目的探讨骨化三醇联合西那卡塞对继发性甲状旁腺功能亢进(SHPT)的治疗效果。方法选取2021年8月至2022年7月于高州市人民医院血液净化中心接受血液透析并发甲状旁腺功能亢进的患者80例,采用随机数表法分为观察组和对照组,每组各40例。在... 目的探讨骨化三醇联合西那卡塞对继发性甲状旁腺功能亢进(SHPT)的治疗效果。方法选取2021年8月至2022年7月于高州市人民医院血液净化中心接受血液透析并发甲状旁腺功能亢进的患者80例,采用随机数表法分为观察组和对照组,每组各40例。在两组患者均维持透析治疗的基础上,对照组给予西那卡塞治疗,观察组给予骨化三醇联合西那卡塞治疗,两组均维持治疗6个月。比较两组临床疗效,收集治疗前后的全段甲状旁腺激素(iPTH)、甲状旁腺体积、血钙水平、血磷水平、钙磷乘积指标进行比较。结果治疗前,两组iPTH、甲状旁腺体积、血钙水平、血磷水平、钙磷乘积差异比较,差异无统计学意义(P>0.05);治疗后,观察组血钙水平高于对照组,iPTH、血磷水平均低于对照组,甲状旁腺体积小于对照组,差异有统计学意义(P<0.05);观察组治疗总有效率优于对照组,差异有统计学意义(P<0.05)。结论骨化三醇联合西那卡塞治疗血液透析患者SHPT的临床效果显著,患者的血钙水平升高而iPTH、血磷水平均降低,甲状旁腺体积缩小,值得临床推广应用。 展开更多
关键词 继发性甲状旁腺功能亢进 骨化三醇 西那卡塞 全段甲状旁腺激素 血清钙 血清磷
下载PDF
甲状旁腺功能亢进与骨质疏松症之间的因果关系:双向两样本孟德尔随机化研究
20
作者 杨捷 李盟 +3 位作者 燕树勋 陈亚琳 巴明玉 宋瑞捧 《河南大学学报(医学版)》 CAS 2024年第4期277-284,共8页
目的:通过双向、两样本孟德尔随机化的方法探讨骨质疏松症与原发性甲状旁腺功能亢进之间的因果关系并判断二者间有无反向因果存在。方法:从英国生物样本数据库(UK Biobank)中获得与骨质疏松症与从芬兰数据库(FinnGen)中获取原发性甲状... 目的:通过双向、两样本孟德尔随机化的方法探讨骨质疏松症与原发性甲状旁腺功能亢进之间的因果关系并判断二者间有无反向因果存在。方法:从英国生物样本数据库(UK Biobank)中获得与骨质疏松症与从芬兰数据库(FinnGen)中获取原发性甲状旁腺功能亢进相关的单核苷酸多态性(SNP),使用随机效应逆方差加权法(Inverse-Variance Weighted,IVW)为主要模型,结合MR-Egger回归、加权中位数法(Weighted Median,WME)、simple mode和基于模式的估计法(weighted mode)四种回归模型评估因果效应,再对其敏感性、异质性、多效性检验以评估结果的稳定性和可靠性。结果:对于筛选后的原发性甲状旁腺功能亢进与骨质疏松症GWAS数据以IVW为主要分析模型,骨质疏松症对原发性甲状旁腺功能亢进IVW结果为OR=0.960,95%CI=0.433~2.13,P=0.551,因果效应无显著性(P>0.05);原发性甲状旁腺功能亢进对骨质疏松症IVW结果为OR=0.998,95%CI=0.996~1.000,P=0.036,因果效应存在统计学意义(P<0.05),多种敏感性分析显示研究不存在敏感性,多效性和异质性,说明结果具有稳健性。结论:利用双向、两样本孟德尔随机化方法从遗传变异角度印证原发性甲状旁腺功能亢进与骨质疏松症之间存在因果关系,且不能从遗传变异角度证明骨质疏松症与原发性甲状旁腺功能亢进的因果关系,贴合临床过程中生理、病理相关机制,二者之间不存在反向因果关系。有助于对骨质疏松症与甲状旁腺功能亢进的临床诊疗,为二者之间发病机制研究提供了参考。 展开更多
关键词 骨质疏松症 原发性甲状旁腺功能亢进 孟德尔随机化 甲状旁腺激素 1 25-双羟维生素D
下载PDF
上一页 1 2 25 下一页 到第
使用帮助 返回顶部